TenQ · fact sheet · filings current to · price as of
Berkshire Hathaway (BRK-B)
The business itself is the question here - 11 of 23 checks passed.
Latest close : $506.03, -0.4% on the day; -4.4% from the 52-week high. Refreshed every trading night.
Full analysis: report · all charts. Financial statements are computed from SEC EDGAR XBRL filings, current to . The share price and everything built on it (market cap, multiples, yields, the Value and Trend checks) are refreshed every trading night; this page shows the close of . Not investment advice.
Key figures
| Share price (delayed close) | $506.03 |
| Market cap | $1.08T |
| 52-week range | $465.40 - $529.42 |
| P/E | 12.6x |
| P/E, own median | - |
| P/S | 4.2x |
| Free cash flow yield | 2.2% |
| Dividend yield | - |
| Revenue (TTM) | $259.7B |
| Net income (TTM) | $85.8B |
| Free cash flow (TTM) | $24.2B |
| Gross margin | - |
| Operating margin | 8.3% |
| Return on equity | 11.5% |
| Revenue growth (1y) | +5.7% |
| Revenue CAGR (3y) | +6.0% |
| Debt / equity | - |
| Cash & short-term investments | $41.4B |
| Shares outstanding | - |
The score: 11 of 23 checks passed
Six chapters, six pass/fail checks each. Five are computed from the filings; Trend is price behaviour, and says so.
Is BRK-B stock cheap or expensive right now?
Value · not scored. Not enough data to score this fairly - the checks below show exactly what's missing. (EBITDA at or below zero, or unavailable; no multiple history; no positive 3-year earnings growth to compare against; und) chapter →
Is Berkshire Hathaway still growing?
Growth · 1 of 4 checks passed. Growth is weak or inconsistent - the trend, not the story, is the problem. chapter →
Does Berkshire Hathaway make real money?
Quality · 1 of 4 checks passed. Profitability is thin or negative - the growth isn't turning into money yet. chapter →
Can Berkshire Hathaway survive a bad year?
Health · 2 of 4 checks passed. The balance sheet carries real risk - read the checks before anything else. chapter →
What does Berkshire Hathaway hand back to shareholders?
Shareholder returns · not scored. Not enough data to score this fairly - the checks below show exactly what's missing. (no dividend in the last three years; under 3 years of share counts) chapter →
Which way is BRK-B trending?
Trend analysis · 4 of 6 checks passed. Mixed signals from the market - some trends up, some rolling over. chapter →
Are insiders buying or selling BRK-B?
Open-market buys: $107M · sells: $2.0B, across the recent Form 4 filings. detail →
Other insurance carriers we cover: UnitedHealth (UNH) · Progressive (PGR) · every company →
Method: figures computed deterministically from SEC EDGAR XBRL (companyfacts, frames, financial-statement-and-notes datasets, Form 4); prices delayed end-of-day. Scores count transparent pass/fail checks. Missing data is shown as missing, never estimated. Last changed . © TenQ - cite with a link to this page.